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study conducted on French blood
donors from September to November
2000 showed low titers of WNV neu-
tralizing antibodies in two donors
originating from the Département du
Var (6). However, to date, no clinical
human cases have been reported in
this area.
WNV must be considered as a
causative agent of meningitis,
encephalitis, and polyradiculoneuritis
during summer and early fall in south-
ern France. Given the capacity of
WNV to cause large outbreaks, the
surveillance will be extended to the
entire Mediterranean coastal area.
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SARS in Teaching
Hospital, Taiwan
To the Editor: During the global
epidemic of severe acute respiratory
syndrome (SARS), the illness was
transmitted rapidly within hospitals,
which created pools of persons who
became infected and through whom
the disease was spread. Intrahospital
transmission amplified regional out-
breaks and augmented spread of the
illness into the community (1–3).
Healthcare workers, hospital patients,
and hospital visitors accounted for
18%–58% of all cases of SARS in the
five countries with the largest out-
breaks (1,2). The concentration of
SARS among hospital staff strained
hospital facilities, personnel, and
finances. 
National Taiwan University
Hospital, established more than 100
years ago, is the first teaching hospital
and the best resource in Taiwan for
managing patients with illnesses that
are difficult to treat. The hospital has
2,400 beds and provides primary and
tertiary care services in Taipei. Taipei
City was among the hardest hit areas
by SARS in the world (3). From
March 10 to July 23, 2003, the hospi-
tal reported 270 patients with SARS,
many of whom were severely ill. The
hospital treated 180 of the 665
patients with SARS reported in
Taiwan, even though it was staffed by
4,450 of the country’s 178,000 health-
care workers. SARS had an impact on
this hospital for three likely reasons.
First, the hospital identified and treat-
ed the first SARS patients in Taiwan
(4,5). Second, it provided easy access
through the emergency room and out-
patient clinics. Febrile persons with a
travel history to SARS-affected areas
or other risk of SARS exposure came
directly to this hospital for care.
Third, many hospitals, particularly
private facilities, were reluctant to
report and admit patients with SARS
during the early stage of the epidemic
because of financial considerations
and fear. 
The hospital felt the brunt of the
epidemic in Taiwan during early May
2003, which paralleled the severity of
the SARS epidemic in Taipei (3,4,6).
The maximal number of SARS
patients admitted to the hospital with-
in 24 hours was 12 on May 3. The
maximal number of SARS patients
reported within 24 hours was 15 on
May 6; 8 patients were transferred to
other hospitals on May 7. However,
18 patients stayed overnight in the
emergency room on May 7.
Subsequently, SARS developed in 12
emergency room healthcare workers
(6,7).
Our preliminary studies showed
that the average inpatient cost for
patients with SARS was not higher
than for patients with pneumonia,
after adjustment for age, sex, and
length of stay (MF Chen, unpub.
data). However, SARS caused finan-
cial and operational disruptions in the
hospital. During this period, hospital
utilization rates decreased. Compared
with the previous year’s rates, outpa-
tient and emergency visits fell to 37%,
inpatient admissions fell to 29%, and
surgical procedures fell to 15%. Bed
occupancy decreased from 86% in
May 2002 to 38% in May 2003.
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SARS also imposed physical and psy-
chological concerns on the healthcare
workers.
During the later stage of the SARS
epidemic, the Taiwan government
offered special financial assistance to
hospitals and healthcare workers as an
incentive to help fight SARS. The
country’s National Health Insurance
program compensated hospitals for
the decrease in revenues, based on the
hospital’s reimbursement amount
before the SARS epidemic. This
measure was effective in motivating
other hospitals to accept patients with
SARS. The proportion of inpatients
with SARS at the hospital dropped
from 79.5% during March 10 to April
23, to 46.2% during April 24 to May
1, to 11.6% during May 2 to July 23.
This financial assistance program
remarkably reduced the impact on the
hospital as other hospitals began treat-
ing patients with SARS. 
Preparations for a medical emer-
gency must address the availability
and quality of medical care as well as
the implications for public health pol-
icy, including political, legal, social,
financial, and ethical issues (1). The
importance of a sound financial poli-
cy cannot be overemphasized. Since
the 1980s, healthcare systems have
become free market enterprises. Laws
and regulations are needed to allow
governments to mobilize the
resources of all hospitals and compen-
sate them during health crises.
Government agencies need to work
together with the healthcare system,
including health insurance systems
and social services, well in advance of
epidemic emergencies to maximize
limited resources and distribute them
equitably. 
Democratic societies must preserve
human rights (including the right to
medical care and freedom from fear),
while respecting and protecting the
rights and safety of hospitals and
healthcare workers. We now face the
potential resurgence of SARS, other
emerging and reemerging infectious
diseases, and the threat of bioterror-
ism. Careful consideration of the
financial issues of hospital manage-
ment should be an important part of
social policy. The emergence of SARS
provides a reminder of the potential
threat to the entire healthcare system
when a new disease suddenly appears.
A major lesson from the SARS experi-
ence is that government planning and
intervention are required.
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Boiling and
Bacillus Spores 
To the Editor: Public health
authorities rely upon “boil water”
advisories to alert consumers if a
potable water supply is deemed unsuit-
able for consumption. Holding water
at a rolling boil for 1 minute will inac-
tivate waterborne pathogens, including
encysted protozoa (1–3). Spores of
Bacillus anthracis, the agent that caus-
es anthrax, are one of the microorgan-
isms most refractory to inactivation by
the boiling water method. This study
was conducted to determine the resist-
ance of spores of B. anthracis Sterne
and three other strains of Bacillus spp.
in boiling water.
B. anthracis Sterne (Colorado
Serum Co., Denver, CO) was grown
on soil extract peptone beef extract
medium (4). Spores were harvested
from the agar plates and washed four
times by centrifugation with sterile
distilled water, treated with 50%
(vol/vol) ethanol while being shaken
at 100 rpm for 2 h, then washed an
additional four times by centrifuga-
tion with sterile distilled water. Spores
of one of the B. cereus strains were
obtained from a commercial source
(Raven Biological Laboratories,
Omaha, NE). Spores were produced
in broth cultures for the other Bacillus
